# Intrathecal Morphine for Inguinal Hernia Repair.

> **NCT02001948** · PHASE4 · COMPLETED · sponsor: **Ankara University** · enrollment: 46 (actual)

## Conditions studied

- Inguinal Hernia
- Nausea
- Vomiting
- Pruritus
- Postoperative Pain

## Interventions

- **DRUG:** intrathecal morphine 0.1 mg combined with intrathecal heavy bupivacaine 7.5 mg
- **DRUG:** intrathecal morphine 0.4 mg combined with intrathecal heavy bupivacaine 7.5 mg
- **DEVICE:** standard monitoring with Datex Ohmeda anesthesia monitor, GE, Finland
- **DRUG:** intravenous cannulation and premedication

## Key facts

- **NCT ID:** NCT02001948
- **Lead sponsor:** Ankara University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2013-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02001948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02001948, "Intrathecal Morphine for Inguinal Hernia Repair.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02001948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*